Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide in the Treatment of Pneumonia
NCT06170372Active, not recruiting
- Sponsor
- Tomsk National Research Medical Centre of the Russian Academy of Sciences
- Start
- Jan 2024
- Primary completion
- Jan 2026
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Randomised trial of nitric oxide in hospital-acquired pneumonia (HAP) and community acquired pneumonia (CAP) (4 arms), sponsored by Tomsk National Research Medical Centre of the Russian Academy of Sciences. Primary endpoint: Pneumonia resolution time at 30 days. Started Jan 2024; status: active, not recruiting.
02
Drugs
nitric oxide
03
Conditions
hospital-acquired pneumonia (HAP)community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT06170372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06170372.